The last lesson covered gepants and ditans as alternatives for treating individual migraine attacks. This lesson looks at a different question: what happens when acute treatment is needed repeatedly? You will learn to read a medication record using the relevant days-per-month thresholds, distinguish a warning pattern from a diagnosis, and understand why changing frequent medication use needs a clinician-supported plan.
Count treatment days, not tablets
Medication-overuse headache (MOH) is a possibility when headaches become frequent or worsen during regular use of acute headache medicines. It can be difficult to untangle cause and effect: more headaches lead someone to take more medicine, while frequent use of some medicines can also help sustain a pattern of headaches. A record helps reveal the pattern, but it cannot establish the cause on its own.
The first counting rule is simple: one medication-use day is a calendar day on which the medicine was taken, regardless of whether one or several doses were taken that day. The second rule is that the threshold depends on the type of medicine. The National Institute for Health and Care Excellence (NICE) gives the following thresholds for being alert to possible MOH when headache has developed or worsened during use over three months or more.
Headaches in over 12s: diagnosis and management
Read NICE recommendation 1.2.7 for the medication-use thresholds. This is the reference for the record-reading method below.
In the PDF's "Medication overuse headache" subsection, recommendation 1.2.7 begins at the bottom of p. 9. Read the warning condition, then continue onto p. 10 from the drug-specific thresholds. Focus on both the number of days and which medicines belong in each group.
| Acute medicine used | Days of use per month that warrant attention |
|---|---|
| Triptans, ergots, opioids, or combination pain relievers | 10 or more |
| Simple pain relievers such as acetaminophen/paracetamol, aspirin, or an NSAID, used alone or in combination with one another | 15 or more |
The accompanying American Migraine Foundation chart gives a visual reminder of the two thresholds. Its “simple analgesics” group includes acetaminophen and NSAIDs; acetaminophen is not itself an NSAID.

A combination pain reliever containing ingredients such as caffeine and other pain medicines belongs in the 10-day group; being sold without a prescription does not make it a 15-day medicine. Conversely, taking an NSAID twice on one day counts as one NSAID-use day, not two. These monthly thresholds are warning signs, not recommended amounts of medication to aim for. Dose limits and other safety considerations still apply well before a monthly threshold is reached.
Read a record across months
Consider this fictional record from someone with a history of migraine. “Both” means a triptan and an NSAID were taken on the same calendar day.
| Month | Headache days | Triptan-use days | NSAID-use days | Days with both |
|---|---|---|---|---|
| 1 | 18 | 10 | 12 | 5 |
| 2 | 20 | 11 | 14 | 6 |
| 3 | 19 | 10 | 13 | 5 |
The triptan meets the 10-day threshold in every month. The NSAID, considered on its own, stays below the 15-day threshold in every month. The overlap does not cancel either count: on a day when both medicines were taken, that day counts once toward triptan use and once toward NSAID use. It is still only one calendar day of any acute-medication use.
The record therefore raises a clear concern about possible medication-overuse headache, particularly if headaches developed or worsened during this period. It does not prove that the triptan caused the headaches. A clinician would want to know what the headache pattern was before these months, whether the medicines were also taken for another condition, what other acute medicines were used, and whether a different cause of worsening headache needs assessment.
Time matters as much as the threshold. If only the latest month showed 10 triptan-use days, the record would not show the same sustained pattern—but the increase could still be worth discussing. Equally, switching between medicines does not necessarily make frequent treatment unimportant. For example, separate acetaminophen and NSAID days must be considered together under NICE’s simple-pain-reliever category; use of several different acute-treatment classes also warrants review even when no single medicine appears frequently used.
The previous lesson noted that gepants have not shown the same established MOH risk as some older acute medicines. That is not a reason to ignore frequent attacks or to apply the chart’s triptan threshold automatically to a gepant. A clinician should review frequent treatment use and the underlying migraine burden regardless of which acute option is being used.
Why the response is a plan, not abrupt self-withdrawal
Recognizing a pattern is useful because it changes the treatment conversation. Simply continuing to treat each increasingly frequent headache may leave the underlying problem unaddressed. But simply stopping a frequently used medicine without support can also go badly: headaches may worsen temporarily during withdrawal, and some medicines need particular care when being reduced.
Read the American Migraine Foundation’s explanation alongside NICE’s management recommendations. The important distinction is between a clinician’s planned withdrawal strategy and someone stopping medication on their own.
Medication Overuse Headache | American Migraine Foundation
The American Migraine Foundation explains why increasing headache and medication use can become difficult to manage, and why reducing overuse may need more than one intervention.
Start in "The Basics of Headache Medication & Overuse" at the opening explanation. Then skip to "What is the treatment of medication-overuse headache?" and read from the treatment discussion. Notice the potential short-term worsening, the possible role of preventive treatment, and the warning about medicines that may require tapering.
Headaches in over 12s: diagnosis and management
Return to the NICE guideline for its emphasis on withdrawal support and follow-up. Its recommendation to stop overused acute headache medicines abruptly is clinical guidance, not an instruction to self-withdraw—especially where opioids or medicines associated with dependence are involved.
In the PDF's "Medication overuse headache" management subsection, read recommendations 1.3.42–1.3.44 on p. 18, beginning with withdrawal guidance and continuing through the recommendation about short-term worsening and close support. Then read recommendations 1.3.45–1.3.48 on p. 19, from prevention and follow-up.
The safe approach depends on the medicine and the person. A clinician may plan withdrawal of an overused acute medicine while also addressing the migraine that led to frequent treatment. That plan may include an alternative way to manage attacks, discussion of preventive treatment, and follow-up while headaches temporarily worsen. Some medicines can be stopped without tapering under an appropriate plan; opioids and butalbital-containing medicines may require a different, supervised withdrawal approach, and abruptly stopping them can be dangerous. Relevant health conditions and previous withdrawal difficulties also affect the plan.
The practical value of a medication record is therefore not to deliver a verdict or a self-treatment instruction. It is to make a clinical discussion more precise: which medicine was taken, on how many days each month, for how long, and alongside what change in headache frequency.
Key takeaways
Possible medication-overuse headache is flagged by sustained, frequent use of particular acute medicines alongside developing or worsening headache. Count calendar days rather than doses: the key thresholds are 10 or more days per month for triptans, ergots, opioids, and combination pain relievers, and 15 or more days per month for simple pain relievers. A three-month record can reveal a concerning pattern, but it does not establish the cause of the headaches.
Reducing overuse calls for a clinician-supported plan, because withdrawal can briefly worsen headaches, the underlying migraine still needs treatment, and some medicines are unsafe to stop abruptly without guidance. The next lesson turns to preventive treatment: when the number of headache days, disability, or repeated need for acute relief makes prevention worth discussing.